Most just lately, it has been determined that conolidine and the above derivatives act within the atypical chemokine receptor 3 (ACKR3. Expressed in similar locations as classical opioid receptors, it binds into a big selection of endogenous opioids. Compared with most opioid receptors, this receptor acts as being a scavenger and doesn't activate a